Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15759000 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine
Conditions: Malaria;   Malaria Vaccines;   Plasmodium Falciparum Malaria
Intervention: Biological: Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
2 Completed Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
Condition: Drug Resistant Malaria Due to Plasmodium Falciparum
Interventions: Drug: Arthemeter-lumefantrine;   Drug: Artesunate mefloquine;   Drug: Dihydroartemisinin piperaquine;   Drug: Paracetamol;   Drug: Amoxicillin;   Drug: Quinine

Study has passed its completion date and status has not been verified in more than two years.